Abstract:Palladin was identified to be specifically expressed in the cytomembrane of patients with NSCLC, suggesting its potential as a cell surface marker for LCSCs identification. More importantly, we demonstrated that Palladin might serve as a tumor oncogene and promote the biological properties of LCSCs, possibly by activating the Wnt/β‐catenin signaling in NSCLC for the first time. The elucidation of this new molecular mechanism for Palladin and Wnt/β‐catenin signaling activation is conducive to understand the pathogenesis of NSCLC, providing a novel possibility of the development of novel therapeutic target for CSCs targeted therapy. Background Cancer stem cells (CSCs) are responsible for drug resistance, cancer relapse, and metastasis. Here, we report the first analysis of Palladin expression and its impacts on stem cell‐like properties in lung cancer. Methods Tissue microarrays were used to investigate Palladin expression and its association with prognosis. Immunofluorescence (IF), flow fluorescence assay, and Western blot were performed to detect Palladin expression in 6 NSCLC cell lines. Cell phenotypes and drug resistance were evaluated. Xenograft models were constructed to confirm the role of Palladin in vivo. Results By using the tissue microarrays, Palladin was identified to be highly expressed in the cytoplasm, specifically in the cytomembrane of NSCLC, and its high expression is associated with poor prognosis. Palladin is widely expressed and enriched in the sphere cells. The in vitro and in vivo studies showed that Palladin promoted stem cell‐like properties, including cell viability, invasion, migration, self‐renewal abilities, taxol resistance, and tumorigenicity. Western blot revealed that Palladin promoted the accumulation of β‐catenin and activated Wnt/β‐catenin signaling. Tissue microarrays analysis further confirmed the positive correlation between Palladin and β‐catenin. Wnt/β‐catenin pathway inhibitor blocked the Palladin‐induced enhancement of sphere‐forming. Conclusions Palladin might act as an oncogene by promoting CSCs‐like properties and tumorigenicity of NSCLC cells via the Wnt/β‐catenin signaling pathway. Besides, Palladin was identified to have the potential as a cell surface marker for LCSCs identification. These findings provide a possible target for developing putative agents targeted to LCSCs.

α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer

Wnt/β-catenin Signaling Pathway in Lung Cancer Stem Cells is a Potential Target for the Development of Novel Anticancer Drugs.

LCAT1 is an Oncogenic LncRNA by Stabilizing the IGF2BP2-CDC6 Axis

Constitutive Expression Of Wnt/Beta-Catenin Target Genes Promotes Proliferation And Invasion Of Liver Cancer Stem Cells

Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.

Long Noncoding RNA LCAT1 Functions As a Cerna to Regulate RAC1 Function by Sponging Mir-4715-5p in Lung Cancer

Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse

Hypoxia differently regulates the proportion of ALDHhi cells in lung squamous carcinoma H520 and adenocarcinoma A549 cells via the Wnt/β‐catenin pathway

Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating β-catenin

CCDC34 Maintains Stemness Phenotype Through Β-Catenin-mediated Autophagy and Promotes EGFR-TKI Resistance in Lung Adenocarcinoma

The Potential Role of Cathepsin K in Non-Small Cell Lung Cancer

LncCCAT1 Promotes Breast Cancer Stem Cell Function Through Activating WNT/β-catenin Signaling.

Palladin promotes cancer stem cell‐like properties in lung cancer by activating Wnt/Β‐Catenin signaling

Reduced CD146 Expression Promotes Tumorigenesis and Cancer Stemness in Colorectal Cancer Through Activating Wnt/β-catenin Signaling.

Ccat1/Fabp5 Promotes Tumour Progression Through Mediating Fatty Acid Metabolism And Stabilizing Pi3k/Akt/Mtor Signalling In Lung Adenocarcinoma

An MST4‐p β ‐Catenin Thr40 Signaling Axis Controls Intestinal Stem Cell and Tumorigenesis

KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability

CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis

Ablation Of P120-Catenin Enhances Invasion And Metastasis Of Human Lung Cancer Cells

Targeting the Wnt-Regulatory Protein CTNNBIP1 by Microrna-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas.

Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells